The National Agency for Food and Drug Administration and Control (NAFDAC) has officially debunked widespread reports alleging that the death of a National Youth Service Corps (NYSC) member in Enugu State was caused by substandard or falsified drugs.
​In a formal statement released on Friday, October 16, 2026, the regulatory agency clarified that medical investigations and laboratory analyses confirmed the medications administered to the deceased were safe, standard, and efficacious.
​The tragedy involved Etimbuk Daniel, a former Students’ Union Government (SUG) President at Akwa Ibom State University, who fell ill while participating in the 2026 Batch Orientation Programme at the NYSC Permanent Orientation Camp in Awgu, Enugu State. After reports surfaced online claiming Daniel died due to counterfeit pharmaceuticals and delayed care, public outcry mounted rapidly.
​The National Association of Nigerian Students (NANS), represented by its President Akinteye Afeez, demanded an immediate investigation into the incident on Sunday, October 11, 2026.
The matter reached the highest levels of government on Thursday, October 15, 2026, when the Nigerian Senate observed a minute of silence and formally ordered a comprehensive probe into the circumstances surrounding Daniel’s death and the broader condition of healthcare facilities across NYSC camps nationwide.
​In response to the public concern and legislative scrutiny, NAFDAC regulatory officers visited the Awgu camp clinic to conduct a full investigation. Inspectors interviewed attending healthcare personnel, audited clinic supply records, and retrieved samples of the administered medications for laboratory analysis.
​According to NAFDAC, the empirical evidence disproved allegations of drug toxicity or falsification. The exact medication batches given to Daniel were simultaneously administered to several other sick corps members at the camp clinic, all of whom recovered fully without complications.
Healthcare personnel at the facility, including medical doctors and pharmacists, had routinely consumed medications from the same inventory batches for their personal health needs.
​Attending physicians and clinical staff reported that Daniel initially presented with severe symptoms that had developed prior to his visit to the clinic. A post-incident review revealed that Daniel had experienced continuous severe vomiting for two days before seeking clinical help, a crucial medical history that was not initially disclosed to the attending medical team.
​Medical doctors at the facility established the preliminary cause of death as acute kidney injury secondary to severe dehydration and hypovolemic shock. Daniel’s condition deteriorated rapidly as he slipped into a coma.
He was immediately rushed under emergency referral to the University of Nigeria Teaching Hospital (UNTH) in Enugu, where emergency resuscitation efforts by specialist doctors ultimately failed.
​Extending condolences to the bereaved family and the student community, NAFDAC reassured the public of its unwavering commitment to safeguarding the national drug supply chain. The agency urged citizens to remain calm and refrain from spreading unverified health claims.
